Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
Cure Today
19h
Keytruda Improves Disease-Free Survival in Some With Urothelial Carcinoma
Among patients with high-risk muscle-invasive urothelial carcinoma, postsurgical Keytruda extended the time some lived ...
Zacks.com on MSN
19h
Pharma Stock Roundup: FDA Approvals for LLY, MRK, AZN & JNJ Drugs
This week, the FDA approved Eli Lilly’s LLY eczema drug, Ebglyss (lebrikizumab), and the expanded use of Novartis’ NVS ...
ThePrint on MSN
22h
This experimental lung cancer drug outperforms blockbuster medicine Keytruda. But there’s a catch
In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Secret Service admits failure
Released after guilty plea
TN abortion law blocked
Jurors begin deliberations
Sesame Place suit verdict
Pandas leaving for China
SC 1st execution in 13 years
Drug price challenge revived
Boeing defense chief exits
Feds subpoena Schaeffer
Russia threatens retaliation
WI high court to decide
FDA approves flu vaccine
Body found in SUV
Hand count approved in GA
144K+ Mavericks recalled
House repeals emission rules
$230 million crypto theft
Bill to boost security OK'd
In-person voting begins
Sues pharmacy middlemen
Top Hezbollah leader killed?
Baby powder recalled
Hiker injured in bear attack
1st rabies outbreak in seals
Stein's ballot bid rejected
MS sheriff's office probe
Recalling 449K+ vehicles
Disney to stop using Slack
$3B for battery projects
Related topics
Pembrolizumab
Summit
Merck
Lung cancer
United States
Feedback